Tharimmune, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Tharimmune, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2021 to Q2 2024.
  • Tharimmune, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$2.33M, a 0.51% increase year-over-year.
  • Tharimmune, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$8.88M, a 0.49% increase year-over-year.
  • Tharimmune, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$9.32M, a 9.98% decline from 2022.
  • Tharimmune, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$8.47M, a 284% decline from 2021.
  • Tharimmune, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$2.21M, a 8.72% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$8.88M -$2.33M +$11.9K +0.51% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$8.89M -$2.26M +$432K +16.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$9.32M -$2.47M -$707K -40% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 -$8.61M -$1.82M +$307K +14.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$8.92M -$2.34M -$700K -42.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$8.22M -$2.69M +$254K +8.64% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$8.47M -$1.77M -$4.22M -172% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 -$4.25M -$2.13M -$1.27M -149% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$2.98M -$1.64M -$80.8K -5.19% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$2.9M -$2.94M -$692K -30.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 -$2.21M $2.45M Oct 1, 2021 Dec 31, 2021 10-K/A 2023-05-22
Q3 2021 -$853K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1.56M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$2.25M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.